Subscribe To
NWBO / Northwest Bio: Buy Again, Wait For Regulatory Process
NWBO News
By Seeking Alpha
October 14, 2023
Northwest Bio: Another Small Filing Delay
Northwest Bio has provided a timeline for submitting an application for approval to the UK equivalent of the US FDA for their GBM therapy. The company more_horizontal
By Seeking Alpha
August 17, 2023
Northwest Bio: Is There Ever Going To Be A Right Time?
Northwest Biotherapeutics is a biotech focused on developing a dendritic cell vaccine to fight cancer. The company has faced financial challenges and more_horizontal
By 24/7 Wall Street
December 1, 2022
Biotech Firm Claims Citadel, Other Market Makers Manipulated Stock Price
US biotech company Northwest Biotherapeutics filed a lawsuit against Citadel Securities and several other market makers, accusing them of lowering the more_horizontal
By InvestorPlace
December 1, 2022
NWBO Stock Alert: Northwest Bio Slams Citadel Securities in New Lawsuit
Shares of Northwest Biotherapeutics (OTCMKTS: NWBO ) are in focus on Thursday. NWBO stock is up about 5% on the day and it's got investors' attention more_horizontal
By Seeking Alpha
November 23, 2022
Northwest Biotherapeutics: Data Is Done, Just Wait For Approval
NWBO published topline data on JAMA Oncology, resoundingly, I must say. Data shows stat sig on all major primary and secondary endpoints. more_horizontal
By Seeking Alpha
May 21, 2022
Northwest Bio: Buy Again, Wait For Regulatory Process
Data is excellent. I explain the bearish commentary here. more_horizontal
By Seeking Alpha
March 5, 2022
Northwest Bio: What A Comparison Analysis Says About Its Progress
Northwest Bio: What A Comparison Analysis Says About Its Progress more_horizontal
By Seeking Alpha
March 5, 2022
Northwest Bio: What A Comparison Analysis Says About Its Progress
Northwest Bio: What A Comparison Analysis Says About Its Progress more_horizontal